From the Radioisotope Laboratory and Department of Medicine, Veterans Administration Hospital and University of Oregon Medical School
Get full access to this article
View all access options for this article.
References
1.
Aldrich, R.A. : Acute Iron Toxicity. Iron in Clinical Medicine . California, Univ. Calif. Press , 1958, pp. 93-104.
2.
Bannerman, R.M. , Callender, S.T. and Williams, D.L.: Effect of desferrioxamine and DTPA in iron overload. Brit. Med. J.2: 1573, 1962.
3.
Bothwell, T.H. and Finch, C.A.: Iron Metabolism. Boston , Little, Brown and Co., 1962.
4.
Clark, W.M., Jr.: Iron Poisoning. Nineteenth Ross Pediatric Research Conference . Metabolism and Function of Iron, 1956, p. 53.
5.
Crosby, W.H. , Conrad, M.E., Jr. and Wheby , M.S.: The rate of iron accumulation in iron storage disease. Blood22: 429, 1963.
6.
Fahey, J.L., Rath, C.E., Princiotto, J.V., Brick, I.B. and Rubin, M.: Evaluation of trisodium calcium diethylentriamine-pentaacetate in iron storage disease. J. Lab. Clin. Med.57: 436, 1961.
7.
Figueroa, W.G. : The Enhancement of Iron Excretion in Iron Storage Diseases. Edited by M. J. Seven and L. A. Johnson. In: Metal-Binding in Medicine. Philadelphia, J. B. Lippincott Co., 1960, pp, 146-153.
8.
Golberg, L. and Smith, J.P.: Iron overloading and hepatic vulnerability. Amer. J. Path.36: 125, 1960.
9.
Hampers, C.L. , Prager, D. and Senior, J.R.: Post-transfusion anicteric hepatitis. New Eng. J. Med.271: 747, 1964.
10.
Hwang, Yun-Fei and Brown, E.B.: Evaluation of deferoxamine in iron overload . Arch. Intern. Med.114: 741, 1964.
11.
Keberle, H. : Treatment of primary and secondary hemochromatosis and acute iron poisoning with a new, potent iron-eliminating agent (desferrioxamine-B) cited by S. Moeschlin and U. Schnider. New Eng. J. Med.269: 57, 1963.
12.
London, I.M. , Bruns, G.P. and Karibian, D.: The regulation of hemoglobin synthesis and the pathogenesis of some hypochromic anemias. Medicine43: 789, 1964.
13.
Mocschiin, S. and Schnider, U.: Treatment of primary and secondary hemochromatosis and acute iron poisoning with a new, potent iron-eliminating agent (desferrioxamine-B) . New Eng. J. Med.269: 57, 1963.
14.
Panel Discussion: Symposium on problems of Cooley's anemia. Ann. N. Y. Acad. Sci.119, art. 2: 736, 1964.
15.
Panel Discussion: Transfusion therapy in Cooley's anemia. Ann. N. Y. Acad. Sci.119, art. 2: 829, 1964.
16.
Schafir, M. : The management of acute poisoning by ferrous sulfate. Pediatrics27: 83, 1961.
17.
Smith, R.S. : Iron excretion in thalassemia major after administration of chelating agents. Brit. Med. J.2: 1577, 1962.
18.
Walsh, J.R. , Mass, R.E., Smith, F.W. and Lange, V.: Desferrioxamine effect on iron excretion in hemochromatosis. Arch. Intern. Med.113: 435, 1964 .
19.
Walsh, J.R. , Mass, R.E., Smith, F.W. and Lange, V.: Iron chelation with deferoxamine in hepatic disease. Gastroent.49: 134, 1965.
20.
Wilson, S.J. , Heath, H.E., Nelson, P.L. and Ens, G.G.: Blood coagualtion in acute iron intoxication . Blood13: 483, 1958.
21.
Wöhler, F.: The Treatment of Hemochromatosis With Desferrioxamine. Edited by F. Gross. In: Iron Metabolism, An International Symposium. Berlin, Göttingen, Heidelberg, Springer-Verlag, 1964 .
22.
Wöhler, F.: Diagnosis of iron storage diseases with desferrioxamine (Desferal test). Tenth Congress International Soc. of Hematology. F:22, 1964.
